AB
AEON BiopharmaClinical-stage biopharmaceutical company developing ABP-450 (prabotulinumtoxinA), a biosimilar to Botox, for therapeutic indications like cervical dystonia and chronic migraine.
1 Pulse story
O
OneMedNetOneMedNet provides a platform for curating and exchanging real-world medical imaging and clinical data from healthcare provider networks to power life sciences, AI development, and academic research.
2 Pulse stories
Total RaisedNot disclosed
Last ValuationNot disclosed
Biotech
Sector
Biotech
2013
Founded
2006
Irvine, California
HQ
Eden Prairie, Minnesota
Public (AEON)
Status
Public (ONMD)
AEON Biopharma investors
No investors on record.
OneMedNet investors
No investors on record.
Data from Value Add Pulse coverage and company research — see the full threads for AEON Biopharma and OneMedNet.